The University of New Mexico Health Sciences Center has received a nearly $2.4 million award to study the safety and effectiveness of bipolar disorder treatments in the United States.

The nationwide study – to be funded over four years by the Patient-Centered Outcomes Research Institute (PCORI) – will compare the outcomes of nine commonly prescribed drugs used to treat bipolar disorder, a lifetime mental illness that causes acute episodes of mania and depression. About six million Americans suffer from the condition.

Read full article here